Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Myelodysplastic Syndrome (MDS) Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type, 2020-2028 (USD Billion)
1.2.3. Myelodysplastic Syndrome (MDS) Treatment Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Myelodysplastic Syndrome (MDS) Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Myelodysplastic Syndrome (MDS) Treatment Market Dynamics
3.1. Myelodysplastic Syndrome (MDS) Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increased R&D spending on new drug development
3.1.1.2. Increasing public awareness
3.1.2. Market Challenges
3.1.2.1. Adverse effects caused by the medicine
3.1.3. Market Opportunities
3.1.3.1. Initiatives by the government to provide targeted therapies and attractive reimbursement policies
Chapter 4. Global Myelodysplastic Syndrome (MDS) Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Billion)
6.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Immune Treatments
6.4.3. Stem Cell Transplant
6.4.4. Other Treatment Types
Chapter 7. Global Myelodysplastic Syndrome (MDS) Treatment Market, by End-User
7.1. Market Snapshot
7.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by End-User, Performance - Potential Analysis
7.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
7.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Specialty Clinics
7.4.3. Other End-Users
Chapter 8. Global Myelodysplastic Syndrome (MDS) Treatment Market, Regional Analysis
8.1. Myelodysplastic Syndrome (MDS) Treatment Market, Regional Market Snapshot
8.2. North America Myelodysplastic Syndrome (MDS) Treatment Market
8.2.1. U.S. Myelodysplastic Syndrome (MDS) Treatment Market
8.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. End-User breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Myelodysplastic Syndrome (MDS) Treatment Market
8.3. Europe Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.3.1. U.K. Myelodysplastic Syndrome (MDS) Treatment Market
8.3.2. Germany Myelodysplastic Syndrome (MDS) Treatment Market
8.3.3. France Myelodysplastic Syndrome (MDS) Treatment Market
8.3.4. Spain Myelodysplastic Syndrome (MDS) Treatment Market
8.3.5. Italy Myelodysplastic Syndrome (MDS) Treatment Market
8.3.6. Rest of Europe Myelodysplastic Syndrome (MDS) Treatment Market
8.4. Asia-Pacific Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.4.1. China Myelodysplastic Syndrome (MDS) Treatment Market
8.4.2. India Myelodysplastic Syndrome (MDS) Treatment Market
8.4.3. Japan Myelodysplastic Syndrome (MDS) Treatment Market
8.4.4. Australia Myelodysplastic Syndrome (MDS) Treatment Market
8.4.5. South Korea Myelodysplastic Syndrome (MDS) Treatment Market
8.4.6. Rest of Asia Pacific Myelodysplastic Syndrome (MDS) Treatment Market
8.5. Latin America Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.5.1. Brazil Myelodysplastic Syndrome (MDS) Treatment Market
8.5.2. Mexico Myelodysplastic Syndrome (MDS) Treatment Market
8.6. Rest of The World Myelodysplastic Syndrome (MDS) Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Accord Healthcare
9.2.3. Bristol-Myers Squibb
9.2.4. Jazz Pharmaceuticals Inc
9.2.5. Novartis AG
9.2.6. Lupin Pharmaceuticals
9.2.7. Otsuka America Pharmaceutical Inc.
9.2.8. Onconova Therapeutics
9.2.9. Takeda Pharmaceutical Company Limited
9.2.10. Astex Pharmaceuticals, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption